TCR affinity and negative regulation limit autoimmunity

被引:120
作者
Gronski, MA
Boulter, JM
Moskophidis, D
Nguyen, LT
Holmberg, K
Elford, AR
Deenick, EK
Kim, HO
Penninger, JM
Odermatt, B
Gallimore, A
Gascoigne, NRJ
Ohashi, PS [1 ]
机构
[1] Univ Toronto, Inst Breast Canc Res, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2C1, Canada
[2] Univ Toronto, Inst Breast Canc Res, Ontario Canc Inst, Dept Immunol, Toronto, ON M5G 2C1, Canada
[3] Cardiff Univ, Sch Med, Dept Med Biochem & Immunol, Cardiff CF14 4XN, S Glam, Wales
[4] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA
[5] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[6] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria
[7] Univ Zurich Hosp, Dept Expt Pathol, Inst Pathol, CH-8091 Zurich, Switzerland
关键词
D O I
10.1038/nm1114
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autoimmune diseases are often mediated by self-reactive T cells, which must be activated to cause immunopathology. One mechanism, known as molecular mimicry, proposes that self-reactive T cells may be activated by pathogens expressing crossreactive ligands(1-3). Here we have developed a model to investigate how the affinity of the T-cell receptor (TCR) for the activating agent influences autoimmunity. Our model shows that an approximately fivefold difference in the TCR affinity for the activating ligand results in a 50% reduction in the incidence of autoimmunity. A reduction in TCR-ligand affinity to approximately 20 times lower than normal does not induce autoimmunity despite the unexpected induction of cytotoxic T lymphocytes (CTLs) and insulitis. Furthermore, in the absence of a key negative regulatory molecule, Cbl-b(4,5), 100% of mice develop autoimmunity upon infection with viruses encoding the lower-affinity ligand. Therefore, autoimmune disease is sensitive both to the affinity of the activating ligand and to normal mechanisms that negatively regulate the immune response.
引用
收藏
页码:1234 / 1239
页数:6
相关论文
共 35 条
  • [1] A structural basis for LCMV immune evasion:: Subversion of H-2Db and H-2Kb presentation of gp33 revealed by comparative crystal structure analyses
    Achour, A
    Michaëlsson, J
    Harris, RA
    Odeberg, J
    Grufman, P
    Sandberg, JK
    Levitsky, V
    Kärre, K
    Sandalova, T
    Schneider, G
    [J]. IMMUNITY, 2002, 17 (06) : 757 - 768
  • [2] T-cell-receptor affinity and thymocyte positive selection
    Alam, SM
    Travers, PJ
    Wung, JL
    Nasholds, W
    Redpath, S
    Jameson, SC
    Gascoigne, NRJ
    [J]. NATURE, 1996, 381 (6583) : 616 - 620
  • [3] Progression of autoimmune diabetes driven by avidity maturation of a T-cell population
    Amrani, A
    Verdaguer, J
    Serra, P
    Tafuro, S
    Tan, RS
    Santamaria, P
    [J]. NATURE, 2000, 406 (6797) : 739 - 742
  • [4] Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b
    Bachmaier, K
    Krawczyk, C
    Kozieradzki, I
    Kong, YY
    Sasaki, T
    Oliveira-dos-Santos, A
    Mariathasan, S
    Bouchard, D
    Wakeham, A
    Itie, A
    Le, J
    Ohashi, PS
    Sarosi, I
    Nishina, H
    Lipkowitz, S
    Penninger, JM
    [J]. NATURE, 2000, 403 (6766) : 211 - 216
  • [5] Bachmann MF, 1998, EUR J IMMUNOL, V28, P3110
  • [6] QUANTIFICATION OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS WITH AN IMMUNOLOGICAL FOCUS ASSAY IN 24-WELL OR 96-WELL PLATES
    BATTEGAY, M
    COOPER, S
    ALTHAGE, A
    BANZIGER, J
    HENGARTNER, H
    ZINKERNAGEL, RM
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1991, 33 (1-2) : 191 - 198
  • [7] Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry?
    Benoist, C
    Mathis, D
    [J]. NATURE IMMUNOLOGY, 2001, 2 (09) : 797 - 801
  • [8] Stable, soluble T-cell receptor molecules for crystallization and therapeutics
    Boulter, JM
    Glick, M
    Todorov, PT
    Baston, E
    Sami, M
    Rizkallah, P
    Jakobsen, BK
    [J]. PROTEIN ENGINEERING, 2003, 16 (09): : 707 - 711
  • [9] Cbl-b regulates the CD28 dependence of T-cell activation
    Chiang, YPJ
    Kole, HK
    Brown, K
    Naramura, M
    Fukuhara, S
    Hu, RJ
    Jang, IK
    Gutkind, JS
    Shevach, E
    Gu, H
    [J]. NATURE, 2000, 403 (6766) : 216 - 220
  • [10] GASCOIGNE NR, 2001, EXPERT REV MOL MED, P1